Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.04 USD | +0.24% | +13.14% | +63.78% |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
Mar. 28 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
Financials (USD)
Sales 2024 * | 38.33M | Sales 2025 * | 54.99M | Capitalization | 2.64B |
---|---|---|---|---|---|
Net income 2024 * | -191M | Net income 2025 * | -222M | EV / Sales 2024 * | 69 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 48.1 x |
P/E ratio 2024 * |
-13.9
x | P/E ratio 2025 * |
-13
x | Employees | 201 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.53% |
1 day | +0.24% | ||
1 week | +13.14% | ||
Current month | +0.02% | ||
1 month | +0.29% | ||
3 months | +32.31% | ||
6 months | +119.60% | ||
Current year | +63.78% |
Managers | Title | Age | Since |
---|---|---|---|
Bill Lundberg
CEO | Chief Executive Officer | 60 | 19-06-11 |
Gregory Perry
DFI | Director of Finance/CFO | 63 | 16-04-30 |
Chief Tech/Sci/R&D Officer | - | 16-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Perry
DFI | Director of Finance/CFO | 63 | 16-04-30 |
Maxine Gowen
BRD | Director/Board Member | 66 | 21-05-27 |
Paolo Pucci
BRD | Director/Board Member | 63 | 20-06-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 45.04 | +0.24% | 822,968 |
24-04-25 | 44.93 | +7.05% | 1,921,425 |
24-04-24 | 41.97 | +2.82% | 741,293 |
24-04-23 | 40.82 | +0.91% | 572,348 |
24-04-22 | 40.45 | +1.61% | 705,458 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.78% | 2.64B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MRUS Stock